Search

everythinglearnresearchcommunity

for

Search:↓

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

HDAC4 and HDAC7 are crucial for Th17 cell development and could be targeted to treat inflammatory diseases.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Targeting regulatory T cells may help treat age-related diseases.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Understanding T cells and signaling pathways can lead to better treatments for hair loss.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

T cells and bacteria in the gut and skin help maintain health and protect against disease.

A substance called miR-1246 may help treat severe hair loss by reducing certain immune cell activities.

Skin organoids with NCSTN mutation show changes in hair follicle development and higher inflammation, key features of Hidradenitis Suppurativa.

IL-26 has antimicrobial and pro-inflammatory effects in the chronic skin condition Hidradenitis Suppurativa.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Targeting the IL-23/IL-17 pathway effectively treats several inflammatory skin diseases.

Faulty Notch signalling may cause hair follicle changes and inflammation in hidradenitis suppurativa.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

Different parts of the body have unique immune characteristics in their skin.

STAT3 signaling is important for healthy skin and hair follicles, and its disruption can lead to skin conditions like atopic dermatitis.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Targeting CD169+ skin macrophages may help treat psoriasis.

Squaric acid dibutylester can cause severe skin reactions in people with allergies.

A patient with Ivemark syndrome developed mixed type vitiligo after a hepatitis C infection, showing different treatment responses and immune cell involvement in the skin.